Literature DB >> 12409074

Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer.

M J Piccart1, F Cardoso, G Atalay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409074     DOI: 10.1016/s0959-8049(02)00285-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  1 in total

Review 1.  Letrozole: a review of its use in postmenopausal women with breast cancer.

Authors:  Dene Simpson; Monique P Curran; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.